Research Articles | Page 8 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes Apr 2016 Anemia myelodysplastic syndromes (MDS)
Spontaneous remision of aplastic anemia occurring during a pregnancy Aug 2012 Ann Biol Clin (Paris) aplastic anemia
Myelodysplastic syndromes: pathophysiology, clinical and biological features Dec 2015 Ann Biol Clin (Paris) myelodysplastic syndromes (MDS)
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Sep 2013 Ann Hematol myelodysplastic syndromes (MDS)
Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide May 2014 Ann Hematol myelodysplastic syndromes (MDS)
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol Aug 2016 Ann Hematol myelodysplastic syndromes (MDS)
Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia Dec 2014 Ann Hematol aplastic anemia
Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents? Oct 2015 Ann Hematol myelodysplastic syndromes (MDS)
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemia Aug 2017 Ann Hematol aplastic anemia
Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT Sep 2016 Ann Hematol myelodysplastic syndromes (MDS)
Share with addtoany.com.